Carrier Screening Market

Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024

Report Code: MD 7435 Nov, 2019, by marketsandmarkets.com

[149 Pages Report] The global carrier screening market size is projected to reach USD 4.0 billion in 2024 from USD 1.8 billion in 2019, growing at a CAGR of 17.5% during the forecast period. Growth in the market can primarily be attributed to factors such as increasing emphasis on early disease detection & prevention and technological advancements in carrier screening. Increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market. On the other hand, a lack of standard guidelines for carrier screening and the dearth of a sufficient workforce may challenge market growth to a certain extent.

Carrier Screening Market

By type, the expanded carrier screening segment is expected to witness above-average growth in the carrier screening market during the forecast period.

By type, the market is segmented into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further segmented into predesigned panel testing and customized panel testing. The largest share of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.

By end user, the hospital segment is expected to grow at the highest CAGR.

On the basis of end user, the market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). The growing patient population, increase in Medicare reimbursement for clinical tests performed in hospitals, and the emergence of advanced diagnostic tests are some of the key factors driving the growth of this end-user segment.

Carrier Screening Market

North America is expected to account for the largest market share during the forecast period.

The global carrier screening market is segmented into North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW). In 2018, North America was the largest regional market for carrier screening, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.

Key Market Players

The major companies in the carrier screening market include Eurofins Scientific (US), Invitae (US), OPKO Health (US), Fulgent Genetics (US), Quest Diagnostics (US), Sema4 (US), Myriad Genetics (US), Illumina (US), and Thermo Fisher Scientific (US).

Invitae (US) was one of the major players operating in the global market in 2018. The company’s major testing services include core, expanded, predesigned, and customized carrier screening testing panels. Invitae’s geographic presence is prominent in North American countries, which primarily focuses on offering carrier screening testing services. Since Invitae’s acquisition of Good Start Genetics in 2017, the company has significantly strengthened its position in the carrier screening testing market.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Values (USD Million)

Segments covered

Product & Service, Type, Technology, Medical Condition, End User, and Region

Geographies covered

North America, Europe, APAC, and RoW

Companies covered

Invitae (US), Fulgent Genetics (US), Illumina (US), Sema4 (US), Natera Inc. (US), LabCorp (US), CENTOGENE (Germany), Thermo Fisher Scientific (US), Myriad Genetics (US), Eurofins Scientific (US), OPKO Health (US),  Fulgent Genetics (US), Quest Diagnostics (US), Luminex Corporation (US), LabCorp (US), BGI Genomics (China), Gene by Gene (US), Progenity (US), Otogenetics Corporation (US), Pathway Genomics (US), MedGenome (US), and True Health (US).

By Product and Service:

  • Service
  • Product

By Type:

  • Expanded Carrier Screening
    • Customized Panel Testing
    • Predesigned Panel Testing
  • Targeted Disease Carrier Screening

By Medical Condition

  • Pulmonary Conditions
  • Hematological Conditions
  • Neurological Conditions
  • Other Conditions

By Technology:

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Other Technologies    

By End User:

  • Hospitals
  • Reference Laboratories
  • Physician Offices & Clinics
  • Other End Users

By Region:

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • RoE
  • Asia Pacific
  • RoW

Key questions addressed by the report:

  • Who are the major market players in the carrier screening market?
  • What are the regional growth trends and the largest revenue-generating regions for the market?
  • What are the major drivers and challenges in the market?
  • What are the major product segments in the market?
  • What are the major end-users for carrier screening?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
    1.4 Years Covered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
    2.2 Market Estimation Methodology
           2.2.1 Revenue Mapping-Based Market Estimation
           2.2.2 Primary Research Validation
    2.3 Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 Market Overview
    4.2 Europe: Market Share, By Type and Country (2019)
    4.3 Market, By Medical Condition
    4.4 Market, By Technology (USD Million) (2019 vs 2024)
    4.5 Market, By End User (USD Million) (2019 vs 2024)

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Emphasis on Early Disease Detection and Prevention
                    5.2.1.2 High Risk of Chromosomal Abnormalities With Advancing Maternal Age
                    5.2.1.3 Technological Advancements
           5.2.2 Opportunities
                    5.2.2.1 Increasing Awareness of Carrier Screening
           5.2.3 Challenges
                    5.2.3.1 Lack of Skilled Professionals
                    5.2.3.2 Lack of Standard Guidelines for Carrier Screening

6 Carrier Screening Market, By Product & Service (Page No. - 40)
    6.1 Introduction
    6.2 Services
           6.2.1 Rising Number of Accredited Laboratories is the Major Indicator of Market Growth
    6.3 Products
           6.3.1 Expanding Use of Carrier Screening Tests has Driven Growth in the Products Market

7 Carrier Screening Market, By Type (Page No. - 45)
    7.1 Introduction
    7.2 Expanded Carrier Screening
           7.2.1 Predesigned Panel Testing
                    7.2.1.1 Predesigned Panel Testing Accounts for the Largest Market Share
           7.2.2 Customized Panel Testing
                    7.2.2.1 Customized Panels Allow for Specific Sets of Conditions to Be Screened
    7.3 Targeted Disease Carrier Screening
           7.3.1 Introduction of Panels Capable of Simultaneously Screening Multiple Conditions has Driven Market Growth

8 Carrier Screening Market, By Medical Condition (Page No. - 52)
    8.1 Introduction
    8.2 Pulmonary Conditions
           8.2.1 Increasing Awareness About Cystic Fibrosis and Customized Services Likely to Boost Market Growth
           8.2.2 Carrier Screening Products/Services for Cystic Fibrosis
    8.3 Hematological Conditions
           8.3.1 Rising Prevalence of Hematological Disorders has Increased the Use of Expanded Carrier Screening Panels
    8.4 Neurological Conditions
           8.4.1 Growing Number of Awareness Programs for Neurological Screening and Presence of Targeted Screening Panels to Support Market Growth
           8.4.2 Global Prevalence of Neurological Conditions
           8.4.3 Carrier Screening Products/Services for Neurological Conditions
    8.5 Other Medical Conditions

9 Carrier Screening Market, By Technology (Page No. - 61)
    9.1 Introduction
    9.2 Dna Sequencing
           9.2.1 Increasing Need to Detect Multiple Genes Simultaneously is Driving Demand for NGS
    9.3 Polymerase Chain Reaction
           9.3.1 Rising Number of Carrier Screening Tests for Targeted Chromosomal Conditions has Increased the Use of PCR
    9.4 Microarrays
           9.4.1 Clinical Validity of Microarray in Carrier Screening has Increased Its Use in Reference Laboratories
    9.5 Other Technologies

10 Carrier Screening Market, By End User (Page No. - 70)
     10.1 Introduction
     10.2 Hospitals
             10.2.1 Hospitals Formed the Largest End-User Segment in the Market
     10.3 Reference Laboratories
             10.3.1 Advantages Offered By Reference Laboratories in Terms of Service Costs and Turnaround Time to Support Market Growth
     10.4 Physician Offices and Clinics
             10.4.1 Large Number of Physician Offices and Clinics are Outsourcing Carrier Screening Testing Services
     10.5 Other End Users

11 Carrier Screening Market, By Region (Page No. - 78)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 US Was the Largest Market for Carrier Screening Products and Services Globally in 2018
             11.2.2 Canada
                        11.2.2.1 Awareness Programs, Campaigns, and Conferences are Promoting Carrier Screening in Canada
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Rising Prevalence of Genetic Disorders to Support Market Growth in Germany
             11.3.2 UK
                        11.3.2.1 High Incidence of Genetic Abnormalities to Drive the Demand for Preconception Screening in the UK
             11.3.3 France
                        11.3.3.1 Government Initiatives Focused on Genomics Research are Expected to Support the Growth of the Market in France
             11.3.4 RoE
     11.4 Asia Pacific
             11.4.1 Increasing Government Support Will Aid the Growth of This Market
     11.5 RoW
             11.5.1 The RoW Market is Significantly Smaller Than Other Regional Markets

12 Competitive Landscape (Page No. - 107)
     12.1 Introduction
     12.2 Market Ranking Analysis
     12.3 Competitive Leadership Mapping (2019)
             12.3.1 Vendor Inclusion Criteria
             12.3.2 Visionary Leaders
             12.3.3 Innovators
             12.3.4 Dynamic Differentiators
             12.3.5 Emerging Companies
     12.4 Competitive Scenario
             12.4.1 Key Product and Service Launches
             12.4.2 Key Acquisitions
             12.4.3 Key Partnerships and Collaborations

13 Company Profile (Page No. - 112)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     13.1 Eurofins Scientific
     13.2 Invitae Corporation
     13.3 Opko Health
     13.4 Fulgent Genetics Inc
     13.5 Quest Diagnostics Incorporated
     13.6 Sema4
     13.7 Myriad Genetics
     13.8 Illumina Inc
     13.9 Thermo Fisher Scientific Inc
     13.10 Luminex Corporation
     13.11 Natera Inc
     13.12 Laboratory Corporation of America Holdings
     13.13 BGI
     13.14 Gene By Gene
     13.15 Progenity
     13.16 Otogenetics Corporation
     13.17 Centogene
     13.18 Pathway Genomics
     13.19 Medgenome
     13.20 True Health

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 143)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Available Customizations
     14.4 Related Reports
     14.5 Author Details


List of Tables (127 Tables)

Table 1 Market, By Product & Service, 2017–2024 (USD Million)
Table 2 Carrier Screening Services Market, By Region, 2017–2024 (USD Million)
Table 3 North America: Carrier Screening Services Market, By Country, 2017–2024 (USD Million)
Table 4 Europe: Carrier Screening Services Market , By Country, 2017–2024 (USD Million)
Table 5 Carrier Screening Products Market, By Region, 2017–2024 (USD Million)
Table 6 North America: Carrier Screening Products Market, By Country, 2017–2024 (USD Million)
Table 7 Europe: Carrier Screening Products Market, By Country, 2017–2024 (USD Million)
Table 8 Market, By Type, 2017–2024 (USD Million)
Table 9 Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 10 Expanded Carrier Screening Market, By Region, 2017–2024 (USD Million)
Table 11 North America: Expanded Carrier Screening Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: Expanded Carrier Screening Market, By Country, 2017–2024 (USD Million)
Table 13 Predesigned Panel Testing Market, By Region, 2017–2024 (USD Million)
Table 14 North America: Predesigned Panel Testing Market, By Country, 2017–2024 (USD Million)
Table 15 Europe: Predesigned Panel Testing Market, By Country, 2017–2024 (USD Million)
Table 16 Customized Panel Testing Market, By Region, 2017–2024 (USD Million)
Table 17 North America: Customized Panel Testing Market, By Country, 2017–2024 (USD Million)
Table 18 Europe: Customized Panel Testing Market, By Country, 2017–2024 (USD Million)
Table 19 Targeted Disease Carrier Screening Market, By Region, 2017–2024 (USD Million)
Table 20 North America: Targeted Disease Carrier Screening Market, By Country, 2017–2024 (USD Million)
Table 21 Europe: Targeted Disease Carrier Screening Market, By Country, 2017–2024 (USD Million)
Table 22 Market, By Medical Condition, 2017–2024 (USD Million)
Table 23 Live Birth Incidence of Cystic Fibrosis
Table 24 Market for Pulmonary Conditions, By Region, 2017–2024 (USD Million)
Table 25 North America: Market for Pulmonary Conditions, By Country, 2017–2024 (USD Million)
Table 26 Europe: Market for Pulmonary Conditions, By Country, 2017–2024 (USD Million)
Table 27 Market for Hematological Conditions, By Region, 2017–2024 (USD Million)
Table 28 North America: Market for Hematological Conditions, By Country, 2017–2024 (USD Million)
Table 29 Europe: Market for Hematological Conditions, By Country, 2017–2024 (USD Million)
Table 30 Market for Neurological Conditions, By Region, 2017–2024 (USD Million)
Table 31 North America: Market for Neurological Conditions, By Country, 2017–2024 (USD Million)
Table 32 Europe: Market for Neurological Conditions, By Country, 2017–2024 (USD Million)
Table 33 Market for Other Medical Conditions, By Region, 2017–2024 (USD Million)
Table 34 North America: Market for Other Medical Conditions, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Other Medical Conditions, By Country, 2017–2024 (USD Million)
Table 36 Market, By Technology, 2017–2024 (USD Million)
Table 37 Comparison of Sequencing Technologies Used By Market Players
Table 38 Market for Dna Sequencing, By Region, 2017–2024 (USD Million)
Table 39 North America: Market for Dna Sequencing, By Country, 2017–2024 (USD Million)
Table 40 Europe: Market for Dna Sequencing, By Country, 2017–2024 (USD Million)
Table 41 Comparison of PCR Technologies Used By Market Players
Table 42 Market for PCR, By Region, 2017–2024 (USD Million)
Table 43 North America: Market for PCR, By Country, 2017–2024 (USD Million)
Table 44 Europe: Market for PCR, By Country, 2017–2024 (USD Million)
Table 45 Comparison of Microarray Technologies Used By Market Players
Table 46 Market for Microarrays, By Region, 2017–2024 (USD Million)
Table 47 North America: Market for Microarrays, By Country, 2017–2024 (USD Million)
Table 48 Europe: Market for Microarrays, By Country, 2017–2024 (USD Million)
Table 49 Market for Other Technologies, By Region, 2017–2024 (USD Million)
Table 50 North America: Market for Other Technologies, By Country, 2017–2024 (USD Million)
Table 51 Europe: Market for Other Technologies, By Country, 2017–2024 (USD Million)
Table 52 Market, By End User, 2017–2024 (USD Million)
Table 53 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 54 North America: Market for Hospitals, By Country, 2017–2024 (USD Million)
Table 55 Europe: Market for Hospitals, By Country, 2017–2024 (USD Million)
Table 56 Market for Reference Laboratories, By Region, 2017–2024 (USD Million)
Table 57 North America: Market for Reference Laboratories, By Country, 2017–2024 (USD Million)
Table 58 Europe: Market for Reference Laboratories, By Country, 2017–2024 (USD Million)
Table 59 Market for Physician Offices and Clinics, By Region, 2017–2024 (USD Million)
Table 60 North America: Market for Physician Offices and Clinics, By Country, 2017–2024 (USD Million)
Table 61 Europe: Market for Physician Offices and Clinics, By Country, 2017–2024 (USD Million)
Table 62 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 63 North America: Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 64 Europe: Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 65 Market, By Region, 2017–2024 (USD Million)
Table 66 North America: Market, By Product & Service, 2017–2024 (USD Million)
Table 67 North America: Market, By Type, 2017–2024 (USD Million)
Table 68 North America: Expanded Market, By Type, 2017–2024 (USD Million)
Table 69 North America: Market, By Technology, 2017–2024 (USD Million)
Table 70 North America: Market, By Medical Condition, 2017–2024 (USD Million)
Table 71 North America: Carrier Screening Market, By End User, 2017–2024 (USD Million)
Table 72 North America: Market, By Country, 2017–2024 (USD Million)
Table 73 US: Market, By Product & Service, 2017–2024 (USD Million)
Table 74 US: Market, By Type, 2017–2024 (USD Million)
Table 75 US: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 76 US: Market, By Technology, 2017–2024 (USD Million)
Table 77 US: Market, By Medical Condition, 2017–2024 (USD Million)
Table 78 US: Market, By End User, 2017–2024 (USD Million)
Table 79 Canada: Market, By Product & Service, 2017–2024 (USD Million)
Table 80 Canada: Market, By Type, 2017–2024 (USD Million)
Table 81 Canada: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 82 Canada: Market, By Technology, 2017–2024 (USD Million)
Table 83 Canada: Market, By Medical Condition, 2017–2024 (USD Million)
Table 84 Canada: Market, By End User, 2017–2024 (USD Million)
Table 85 Europe: Market, By Product & Service, 2017–2024 (USD Million)
Table 86 Europe: Market, By Type, 2017–2024 (USD Million)
Table 87 Europe: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 88 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 89 Europe: Market, By Medical Condition, 2017–2024 (USD Million)
Table 90 Europe: Market, By End User, 2017–2024 (USD Million)
Table 91 Europe: Market, By Country, 2017–2024 (USD Million)
Table 92 Germany: Market, By Product & Service, 2017–2024 (USD Million)
Table 93 Germany: Market, By Type, 2017–2024 (USD Million)
Table 94 Germany: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 95 Germany: Market, By Technology, 2017–2024 (USD Million)
Table 96 Germany: Market, By Medical Condition, 2017–2024 (USD Million)
Table 97 Germany: Market, By End User, 2017–2024 (USD Million)
Table 98 UK: Market, By Product & Service, 2017–2024 (USD Million)
Table 99 UK: Market, By Type, 2017–2024 (USD Million)
Table 100 UK: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 101 UK: Market, By Technology, 2017–2024 (USD Million)
Table 102 UK: Market, By Medical Condition, 2017–2024 (USD Million)
Table 103 UK: Market, By End User, 2017–2024 (USD Million)
Table 104 France: Market, By Product & Service, 2017–2024 (USD Million)
Table 105 France: Market, By Type, 2017–2024 (USD Million)
Table 106 France: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 107 France: Market, By Technology, 2017–2024 (USD Million)
Table 108 France: Market, By Medical Condition, 2017–2024 (USD Million)
Table 109 France: Market, By End User, 2017–2024 (USD Million)
Table 110 RoE: Market, By Product & Service, 2017–2024 (USD Million)
Table 111 RoE: Market, By Type, 2017–2024 (USD Million)
Table 112 RoE: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 113 RoE: Market, By Technology, 2017–2024 (USD Million)
Table 114 RoE: Market, By Medical Condition, 2017–2024 (USD Million)
Table 115 RoE: Market, By End User, 2017–2024 (USD Million)
Table 116 Asia Pacific: Market, By Product & Service, 2017–2024 (USD Million)
Table 117 Asia Pacific: Market, By Type, 2017–2024 (USD Million)
Table 118 Asia Pacific: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 119 Asia Pacific: Market, By Technology, 2017–2024 (USD Million)
Table 120 Asia Pacific: Market, By Medical Condition, 2017–2024 (USD Million)
Table 121 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 122 RoW: Market, By Product & Service, 2017–2024 (USD Million)
Table 123 RoW: Market, By Type, 2017–2024 (USD Million)
Table 124 RoW: Expanded Carrier Screening Market, By Type, 2017–2024 (USD Million)
Table 125 RoW: Market, By Technology, 2017–2024 (USD Million)
Table 126 RoW: Market, By Medical Condition, 2017–2024 (USD Million)
Table 127 RoW: Market, By End User, 2017–2024 (USD Million)


List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries: Carrier Screening Market
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Market
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Technology, 2018
Figure 7 Market, By Product & Service, 2018
Figure 8 Market, By Medical Condition, 2018
Figure 9 Market, By End User, 2018
Figure 10 Geographical Snapshot of the Market
Figure 11 Rising Global Genetic Disease Burden and Increasing Focus on Early Carrier Screening are Driving the Market
Figure 12 Germany Dominates the European Market for Carrier Screening
Figure 13 Pulmonary Conditions Accounted for Largest Market Share in 2018
Figure 14 Dna Sequencing Segment Dominates the Carrier Screening Market
Figure 15 Hospitals to Hold the Largest Market Share During 2019–2024
Figure 16 Carries Screening Market: Drivers, Opportunities, and Challenges
Figure 17 Market: Geographic Growth Opportunities
Figure 18 North America: Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Rank of Companies in the Market, 2018
Figure 21 MnM Dive-Vendor Comparison Matrix: Market
Figure 22 Eurofins Scientific: Company Snapshot (2018)
Figure 23 Invitae: Company Snapshot (2018)
Figure 24 Opko Health: Company Snapshot (2018)
Figure 25 Fulgent Genetics: Company Snapshot (2018)
Figure 26 Quest Diagnostics: Company Snapshot (2018)
Figure 27 Myriad Genetics: Company Snapshot (2018)
Figure 28 Illumina: Company Snapshot (2018)
Figure 29 Thermo Fisher Scientific: Company Snapshot (2018)
Figure 30 Luminex: Company Snapshot (2018)
Figure 31 Natera: Company Snapshot (2018)
Figure 32 Labcorp: Company Snapshot (2018)

The study involved four major activities in estimating the current market size for the carrier screening market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various sources such as Bloomberg BusinessWeek, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for a technical, market-oriented, and commercial study of the market. Secondary research was mainly used to obtain vital information about the industry’s supply chain, the total pool of key players, market classification, and segmentation according to industry trends to the bottom-most level and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The carrier screening market comprises several stakeholders, such as carrier screening product and service providers, suppliers, genetic counselors for carrier screening, and regulatory organizations in the supply chain. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in hospitals and other end users. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is the profile breakup of primary respondents:

Carrier Screening Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the market. These approaches were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • Key product and service providers in the global market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, Directors, and marketing executives
  • All percentage shares, splits, and breakdowns for the global market were determined by using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the carrier screening industry.

Report Objectives

  • To define, describe, segment, and forecast the market by product & service, medical condition, technology, type, end user, and region.
  • To provide detailed information about factors influencing market growth (
  • , and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in Europe, North America, the Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile key players and comprehensively analyze their core competencies in terms of key developments, product portfolios, and financials
  • To track and analyze competitive developments such as partnerships & collaborations, product & service launches, and expansions in the market
Report Code
MD 7435
Published ON
Nov, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Carrier Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home